Financhill
Back

Bumble, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
33

BMBL
Bumble, Inc.

Last Price:
$3.55
Seasonality Move:
-29.87%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$47.03
Seasonality Move:
11.58%
Sell
33
Bumble, Inc. (BMBL) is a Sell

Is Bumble, Inc. a Buy, Sell or Hold?

  • The current Bumble, Inc. [BMBL] share price is $3.53. The Score for BMBL is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • BMBL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMBL Stock Price Chart

What is Bumble, Inc.'s stock price today?

  • The Bumble, Inc. share price today is $3.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMBL is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

BMBL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 38.33 Sell
Chaikin Money Flow: 1935455 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.43 - 3.79) Sell
Bollinger Bands (100): (4.24 - 6.92) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.73 - 61.13) Sell
Bollinger Bands (100): (33.63 - 62.73) Buy

BMBL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.62 Sell
20-day SMA: 3.57 Sell
50-day SMA: 4.49 Sell
200-day SMA: 5.46 Sell
8-day EMA: 3.59 Sell
20-day EMA: 3.74 Sell
50-day EMA: 4.39 Sell
200-day EMA: 5.77 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Bumble, Inc. Earnings Growth & BMBL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $1.42 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Bumble, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):